Stop-codon and C-terminal Nonsense Mutations Are Associated with a Lower Risk of Cardiac Events in Patients with Long QT Syndrome Type 1

Overview

Journal Heart Rhythm

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2015 Aug 31

PMID 26318259

Citations 11

Authors

Martin H Ruwald

Xiaorong Xu Parks

Arthur J Moss

Wojciech Zareba

Jayson Baman

Scott McNitt

Jorgen K Kanters

Wataru Shimizu

Arthur A Wilde

Christian Jons

Coeli M Lopes

Affiliations

Soon will be listed here.

Abstract

Background: In long QT syndrome type 1 (LQT1), the location and type of mutations have been shown to affect the clinical outcome. Although haploinsufficiency, including stop-codon and frameshift mutations, has been associated with a lower risk of cardiac events in patients with LQT1, nonsense mutations have been presumed functionally equivalent.

Objective: The purpose of this study was to evaluate clinical differences between patients with nonsense mutations.

Methods: The study sample comprised 1090 patients with genetically confirmed mutations. Patients were categorized into 5 groups, depending on mutation type and location: missense not located in the high-risk cytoplasmic loop (c-loop) (n = 698), which is used as reference; missense c-loop (n = 192); stop-codon (n = 67); frameshift (n = 39); and others (n = 94). The primary outcome was a composite end point of syncope, aborted cardiac arrest, and long QT syndrome-related death (cardiac events). Outcomes were evaluated using the multivariate Cox proportional hazards regression analysis. Standard patch clamp techniques were used.

Results: Compared to patients with missense non-c-loop mutations, the risk of cardiac events was reduced significantly in patients with stop-codon mutations (hazard ratio [HR] 0.57; 95% confidence interval [CI] 0.34-0.96; P = .035), but not in patients with frameshift mutations (HR 1.01; 95% CI 0.58-1.77; P = .97). Our data suggest that currents of the most common stop-codon mutant channel (Q530X) were larger than those of haploinsufficient channels (wild type: 42 ± 6 pA/pF, n = 20; Q530X+wild type: 79 ± 14 pA/pF, n = 20; P < .05) and voltage dependence of activation was altered.

Conclusion: Stop-codon mutations are associated with a lower risk of cardiac events in patients with LQT1, while frameshift mutations are associated with the same risk as the majority of the missense mutations. Our data indicate functional differences between these previously considered equivalent mutation subtypes.

Citing Articles

Role of Cardiovascular Magnetic Resonance in the Management of Atrial Fibrillation: A Review.

Tore D, Faletti R, Biondo A, Carisio A, Giorgino F, Landolfi I J Imaging. 2022; 8(11).

PMID: 36354873 PMC: 9696856. DOI: 10.3390/jimaging8110300.

Eosinophilic Infiltration of the Sino-Atrial Node in Sudden Cardiac Death Caused by Long QT Syndrome.

Grassi S, Campuzano O, Coll M, Cazzato F, Iglesias A, Ausania F Int J Mol Sci. 2022; 23(19).

PMID: 36232963 PMC: 9569895. DOI: 10.3390/ijms231911666.

Membrane pools of phosphatidylinositol-4-phosphate regulate KCNQ1/KCNE1 membrane expression.

Braun C, Parks X, Qudsi H, Lopes C Commun Biol. 2021; 4(1):1392.

PMID: 34907346 PMC: 8671492. DOI: 10.1038/s42003-021-02909-1.

Atrial fibrillation and atrial cardiomyopathies.

Baman J, Cox J, McCarthy P, Kim D, Patel R, Passman R J Cardiovasc Electrophysiol. 2021; 32(10):2845-2853.

PMID: 33993617 PMC: 9008743. DOI: 10.1111/jce.15083.

A cryptic splice-altering KCNQ1 variant in trans with R259L leading to Jervell and Lange-Nielsen syndrome.

Torrado M, Fernandez G, Ganoza C, Maneiro E, Garcia D, Sonicheva-Paterson N NPJ Genom Med. 2021; 6(1):21.

PMID: 33664273 PMC: 7933243. DOI: 10.1038/s41525-021-00183-y.

References

Tranebjaerg L, Bathen J, Tyson J, Bitner-Glindzicz M . Jervell and Lange-Nielsen syndrome: a Norwegian perspective. Am J Med Genet. 2000; 89(3):137-46. View

Wei J, Fish F, Myerburg R, Roden D, George Jr A . Novel KCNQ1 mutations associated with recessive and dominant congenital long QT syndromes: evidence for variable hearing phenotype associated with R518X. Hum Mutat. 2000; 15(4):387-8. DOI: 10.1002/(SICI)1098-1004(200004)15:4<387::AID-HUMU26>3.0.CO;2-T. View

Splawski I, Shen J, Timothy K, Lehmann M, Priori S, Robinson J . Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000; 102(10):1178-85. DOI: 10.1161/01.cir.102.10.1178. View

Wilde A, Escande D . LQT genotype-phenotype relationships: patients and patches. Cardiovasc Res. 2001; 51(4):627-9. DOI: 10.1016/s0008-6363(01)00389-3. View

Huang L, Bitner-Glindzicz M, Tranebjaerg L, Tinker A . A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res. 2001; 51(4):670-80. DOI: 10.1016/s0008-6363(01)00350-9. View

Sinilnikova O, Stoppa-Lyonnet D, Lenoir G, Mazoyer S . The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum Mol Genet. 2002; 11(23):2805-14. DOI: 10.1093/hmg/11.23.2805. View

Shimizu W, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M . Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. J Am Coll Cardiol. 2004; 44(1):117-25. DOI: 10.1016/j.jacc.2004.03.043. View

Guo S, Lin D . Regression analysis of multivariate grouped survival data. Biometrics. 1994; 50(3):632-9. View

Splawski I, Tristani-Firouzi M, Lehmann M, Sanguinetti M, Keating M . Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet. 1997; 17(3):338-40. DOI: 10.1038/ng1197-338. View

10.

Larsen L, Fosdal I, Andersen P, Kanters J, Vuust J, Wettrell G . Recessive Romano-Ward syndrome associated with compound heterozygosity for two mutations in the KVLQT1 gene. Eur J Hum Genet. 1999; 7(6):724-8. DOI: 10.1038/sj.ejhg.5200323. View

11.

Amrani N, Ganesan R, Kervestin S, Mangus D, Ghosh S, Jacobson A . A faux 3'-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay. Nature. 2004; 432(7013):112-8. DOI: 10.1038/nature03060. View

12.

Moss A, Schwartz P . 25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. Circulation. 2005; 111(9):1199-201. DOI: 10.1161/01.CIR.0000157069.91834.DA. View

13.

Kuzmiak H, Maquat L . Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol Med. 2006; 12(7):306-16. DOI: 10.1016/j.molmed.2006.05.005. View

14.

Hobbs J, Peterson D, Moss A, McNitt S, Zareba W, Goldenberg I . Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA. 2006; 296(10):1249-54. DOI: 10.1001/jama.296.10.1249. View

15.

Khajavi M, Inoue K, Lupski J . Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet. 2006; 14(10):1074-81. DOI: 10.1038/sj.ejhg.5201649. View

16.

Sermet-Gaudelus I, Renouil M, Fajac A, Bidou L, Parbaille B, Pierrot S . In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study. BMC Med. 2007; 5:5. PMC: 1852113. DOI: 10.1186/1741-7015-5-5. View

17.

Moss A, Shimizu W, Wilde A, Towbin J, Zareba W, Robinson J . Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007; 115(19):2481-9. PMC: 3332528. DOI: 10.1161/CIRCULATIONAHA.106.665406. View

18.

Rowe S, Varga K, Rab A, Bebok Z, Byram K, Li Y . Restoration of W1282X CFTR activity by enhanced expression. Am J Respir Cell Mol Biol. 2007; 37(3):347-56. PMC: 1994229. DOI: 10.1165/rcmb.2006-0176OC. View

19.

Teng S, Gao L, Paajanen V, Pu J, Fan Z . Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels. Cardiovasc Res. 2009; 83(3):473-80. PMC: 2709462. DOI: 10.1093/cvr/cvp116. View

20.

Yang T, Chung S, Zhang W, Mullins J, McCulley C, Crawford J . Biophysical properties of 9 KCNQ1 mutations associated with long-QT syndrome. Circ Arrhythm Electrophysiol. 2009; 2(4):417-26. PMC: 2748886. DOI: 10.1161/CIRCEP.109.850149. View